Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Overkamp · SciRah

Researcher profile · Semantic Scholar

F. Overkamp

Share profile

F. Overkamp — researcher profile on SciRah

h-index: 22
Works: 122
Citations: 2,510

Most-cited papers

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martín, F. Holmes, B. Ejlertsen, S. Delaloge +496 more
2017The Lancet Oncology512 citations
Semantic Scholar
Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial
Yasmin Issa-Nummer, S. Darb-Esfahani, S. Loibl, G. Kunz +17 more
2013PLoS ONE205 citations Open access
Semantic Scholar
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.
X. Pivot, J. Gligorov, V. Müller, G. Curigliano +88 more
2014Annals of Oncology186 citations Open access
Semantic Scholar
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.
G. von Minckwitz, S. Loibl, M. Untch, H. Eidtmann +132 more
2014Annals of Oncology134 citations Open access
Semantic Scholar
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
R. Bell, Julia M. Brown, M. Parmar, M. Toi +17 more
2016Annals of Oncology97 citations Open access
Semantic Scholar
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network.
P. Fasching, S. Brucker, T. Fehm, F. Overkamp +13 more
2015Geburtshilfe und Frauenheilkunde87 citations Open access
Semantic Scholar
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on Prognosis
P. Fasching, S. Yadav, Chun-Ling Hu, M. Wunderle +33 more
2021Journal of Clinical Oncology76 citations Open access
Semantic Scholar
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry.
V. Müller, N. Nabieva, L. Häberle, F. Taran +21 more
2018Breast66 citations Open access
Semantic Scholar
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
A. Hartkopf, J. Huober, B. Volz, N. Nabieva +29 more
2018Breast63 citations Open access
Semantic Scholar
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status.
A. Hein, A. Hartkopf, J. Emons, M. Lux +26 more
2021European Journal of Cancer56 citations
Semantic Scholar
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network
Carlo Fremd, C. Hack, A. Schneeweiss, G. Rauch +19 more
2017Archives of Gynecology and Obstetrics52 citations
Semantic Scholar
Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment.
C. Jehn, I. Diel, F. Overkamp, A. Kurth +3 more
2016Anticancer Research52 citations
Semantic Scholar
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
M. Lux, N. Nabieva, A. Hartkopf, J. Huober +27 more
2018Cancers48 citations Open access
Semantic Scholar
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis
P. Fasching, A. Hartkopf, P. Gass, L. Häberle +31 more
2018Breast Cancer Research and Treatment46 citations
Semantic Scholar
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry
M. Wallwiener, F. Heindl, S. Brucker, F. Taran +27 more
2017Geburtshilfe und Frauenheilkunde30 citations Open access
Semantic Scholar
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients
A. Hein, P. Gass, C. Walter, F. Taran +22 more
2016Breast Cancer Research and Treatment30 citations
Semantic Scholar
Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel
H. Kolberg, A. Schneeweiss, T. Fehm, A. Wöckel +17 more
2019Geburtshilfe und Frauenheilkunde29 citations Open access
Semantic Scholar
Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study
R. Wuerstlein, R. Kates, O. Gluz, E. Grischke +27 more
2019Breast Cancer Research and Treatment27 citations Open access
Semantic Scholar
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
T. Decker, F. Overkamp, S. Rösel, A. Nusch +4 more
2017BMC Cancer25 citations Open access
Semantic Scholar
Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
W. Janni, A. Schneeweiss, V. Müller, A. Wöckel +13 more
2019Geburtshilfe und Frauenheilkunde24 citations Open access
Semantic Scholar
Update Breast Cancer 2018 (Part 2) – Advanced Breast Cancer, Quality of Life and Prevention
A. Schneeweiss, M. Lux, W. Janni, A. Hartkopf +18 more
2018Geburtshilfe und Frauenheilkunde23 citations Open access
Semantic Scholar
Update Breast Cancer 2017 – Implementation of Novel Therapies
M. Lux, W. Janni, A. Hartkopf, N. Nabieva +17 more
2017Geburtshilfe und Frauenheilkunde22 citations Open access
Semantic Scholar
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
C. Schimanski, S. Kasper, S. Hegewisch-Becker, Jan Schröder +16 more
2020Oncoimmunology21 citations Open access
Semantic Scholar
Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer
F. Schütz, P. Fasching, M. Welslau, A. Hartkopf +15 more
2019Geburtshilfe und Frauenheilkunde20 citations Open access
Semantic Scholar
Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers
F. Taran, A. Schneeweiss, M. Lux, W. Janni +18 more
2018Geburtshilfe und Frauenheilkunde20 citations Open access
Semantic Scholar
Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristics
P. Fasching, Chun-Ling Hu, S. Hart, E. Polley +25 more
201820 citations
Semantic Scholar
Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies
A. Schneeweiss, A. Hartkopf, V. Müller, A. Wöckel +15 more
2020Geburtshilfe und Frauenheilkunde19 citations Open access
Semantic Scholar
Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
M. Welslau, A. Hartkopf, V. Müller, A. Wöckel +16 more
2019Geburtshilfe und Frauenheilkunde19 citations Open access
Semantic Scholar
Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC).
D. Strumberg, B. Schultheis, M. Ebert, Andrea Kerkhoff +14 more
201319 citations
Semantic Scholar
Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
E. Herrmann, Norbert Marschner, M. Grimm, Carsten Ohlmann +6 more
2011World journal of urology19 citations
Semantic Scholar
Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer
A. Hartkopf, V. Müller, A. Wöckel, M. Lux +13 more
2019Geburtshilfe und Frauenheilkunde18 citations Open access
Semantic Scholar
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
C. Schimanski, M. Möhler, M. Schön, E. Van Cutsem +20 more
2012BMC Cancer18 citations Open access
Semantic Scholar
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study
L. Bergmann, P. Goebell, U. Kube, M. Kindler +12 more
2013Oncology Research and Treatment16 citations Open access
Semantic Scholar
Translational highlights in breast cancer research and treatment: recent developments with clinical impact
P. Fasching, A. Schneeweiss, H. Kolberg, J. Ettl +3 more
2019Current Opinion in Obstetrics and Gynecology15 citations
Semantic Scholar
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial
M. Janning, V. Müller, E. Vettorazzi, M. Cubas-Cordova +24 more
2019International Journal of Cancer15 citations Open access
Semantic Scholar
Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics
D. Lüftner, A. Schneeweiss, A. Hartkopf, V. Müller +15 more
2020Geburtshilfe und Frauenheilkunde14 citations Open access
Semantic Scholar
Translational Highlights in Breast and Ovarian Cancer 2019 – Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy
A. Hartkopf, V. Müller, A. Wöckel, M. Lux +15 more
2019Geburtshilfe und Frauenheilkunde14 citations Open access
Semantic Scholar
ABC3 Consensus: Assessment by a German Group of Experts
C. Thomssen, D. Augustin, J. Ettl, R. Haidinger +11 more
2016Breast Care14 citations Open access
Semantic Scholar
Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer
H. Tesch, V. Müller, A. Wöckel, J. Ettl +15 more
2020Geburtshilfe und Frauenheilkunde13 citations Open access
Semantic Scholar
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3)
Markus Moehler, G. Folprecht, V. Heinemann, J. Holch +18 more
2021International Journal of Cancer12 citations Open access
Semantic Scholar
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
L. Michel, A. Hartkopf, P. Fasching, H. Kolberg +26 more
2020Cancers11 citations Open access
Semantic Scholar
Update Breast Cancer 2020 Part 3 – Early Breast Cancer
J. Huober, A. Schneeweiss, A. Hartkopf, V. Müller +15 more
2020Geburtshilfe und Frauenheilkunde11 citations Open access
Semantic Scholar
Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer
A. Wöckel, M. Lux, W. Janni, A. Hartkopf +16 more
2018Geburtshilfe und Frauenheilkunde11 citations Open access
Semantic Scholar
Abstract P3-11-07: Factors associated with first line chemotherapy use in patients with hormone receptor positive, HER2 negative metastatic breast cancer – data from the PRAEGNANT breast cancer registry
J. Huober, P. Fasching, F. Taran, B. Volz +27 more
20187 citations
Semantic Scholar
Abstract P5-21-09: Overall survival of metastatic breast cancer patients – data from the PRAEGNANT breast cancer registry
F. Taran, P. Fasching, B. Volz, J. Huober +27 more
20187 citations
Semantic Scholar
Outcome of patients with KRAS exon 2 wildtype (KRAS-wt) metastatic colorectal carcinoma (mCRC) with cetuximab-based first-line treatment in the noninterventional study ERBITAG and impact of comorbidity and age.
S. Sahm, T. Goehler, C. Hering-Schubert, J. Janssen +6 more
20167 citations
Semantic Scholar
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
M. Lux, A. Schneeweiss, A. Hartkopf, V. Müller +16 more
2021Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
E. Laakmann, J. Emons, F. Taran, W. Janni +27 more
2020Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
Prognostic and Predictive Factors in Metastatic Breast Cancer
P. Fasching, S. Brucker, T. Fehm, F. Overkamp +13 more
20156 citations
Semantic Scholar
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer
D. Lüftner, A. Hartkopf, M. Lux, F. Overkamp +15 more
2021Breast Care5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Tesch×34
Invite
H. Tesch — researcher profile on SciRah
W. Janni×33
Invite
W. Janni — researcher profile on SciRah
A. Schneeweiss×33
Invite
A. Schneeweiss — researcher profile on SciRah
T. Fehm×33
Invite
T. Fehm — researcher profile on SciRah

×32

Invite

E. Belleville — researcher profile on SciRah

D. Lüftner×32

Invite

D. Lüftner — researcher profile on SciRah

P. Fasching×32

Invite

P. Fasching — researcher profile on SciRah

Invite

M. Lux — researcher profile on SciRah

Invite

J. Ettl — researcher profile on SciRah

Invite

V. Müller — researcher profile on SciRah

A. Hartkopf×29

Invite

A. Hartkopf — researcher profile on SciRah

Invite

H. Kolberg — researcher profile on SciRah